Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography

Human Genetics

Volumn 111, Issue 2, 2002, Pages 128-135

  Jee, Sun Ha ^a   Song, Kyung Soon ^b   Shim, Won Heum ^b   Kim, Hyun Kyung ^b   Suh, Il ^b   Park, Jung Yong ^a   Won, So Young ^a   Beaty, Terri H ^c  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALLELE; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FAMILIAL INCIDENCE; FEMALE; FOLIC ACID BLOOD LEVEL; GENE CONTROL; GENE MUTATION; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HERITABILITY; HUMAN; INFORMATION PROCESSING; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECESSIVE INHERITANCE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME SEGREGATION; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FAMILY; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PEDIGREE; VITAMIN B 12;

EID: 0036705558     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0757-8     Document Type: Article

References (31)

1. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ (1996) Genetic analysis of thermolabile methylene-tetrahydrofolate reductase as a risk factor for myocardial infarction. Quart J Med 89:437-44
2. Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52
3. Boers GHJ, Smals AGH, Trijbels JMF, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WT, et al. (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709-715
4. Bonny GE (1984) On the statistical determination of major gene mechanisms in continuous human traits: Regressive models. Am J Med Genet 18:731-749
5. Cannings E, Thompson EA, Skolnick MH (1978) Probability functions on complex pedigrees. Adv Appl Prob 10:26-61
6. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest J, Rosen R (1997) Arterioscler Thromb Vasc Biol 17:569-573
7. Clauss A (1957) Gerinnungs physiologische Schnell methode Zur Bestimmung des fibrigens. Acta Haematol 17:237-246
8. Demenais FM, Bonney GE (1989) Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits. Genet Epidemiol 6:597-617
9. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
10. Geisel J, Zimbelmann I, Schorr H, Knapp JP, Bodis M, Hubner U, Herrmann W (2001) Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 39:698-704
11. Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR (1990) Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 16:1114-1119
12. Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995) Seven novel mutations in the methyenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methyenetetrahydrofolate reductase deficiency. Am J Hum Genet 56:1052-1059
13. Jee SH, Song KS, Shim W, Kim HK, Suh I, Yoon YS, Beaty TH (2002) Genetic contribution to factor VII levels in families of patients undergoing coronary arteriography. Blood Coagul Fibrinolysis 13:25-33
14. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JWG, Young IS, et al. (1999) Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17:298-309
15. Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545
16. Kang S-S, Wong PWK, Malinow MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12:279-298
17. Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, et al. (1995) Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost 73: 617-622
18. Kim HK, Song KS, Park Q, et al. (1999) Coagulation factor VII activity and R353Q polymorphism in coronary artery disease. Korean J Clin Pathol 19:486-490
19. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410-2416
20. McKinley MC, Strain JJ, McPartlin J, Scott JM, McNulty H (2001) Plasma homocysteine is not subject to seasonal variation. Clin Chem 47:1430-1436
21. Reed T, Malinow MR, Hunt SC, Upson B, Wu LL, Hopkins PN, Stults BN, Kuida H (1990) Estimates of heritability of plasma homocyst(e)ine levels in aging adult male twins. Clin Genet 39:425-428
22. Rice T, Despres JP, Daw EW et al (1997) Familial resemblance for abdominal visceral fat: The Heritage family study. Int J Obes Relat Metab Disord 21:1024-1031
23. S.A.G.E. (1997) Statistical Analysis for Genetic Epidemiology, Release 3.1. Computer program package available from department of epidemiology and biostatistics, Rammelkamp center for education and research, Metrohealth campus, Case Western Reserve University, Cleveland
24. Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J (1996) Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 94:1812-1814
25. Sebastio G, Sperandeo MP, Panico M, De Franchis R, Kraus JP, Andria G (1995) The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutation. Am J Hum Genet 56:1324-1333
26. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 270:2693-2698
27. Van Der Put NMJ, Van Der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JMF, Eskes TKAB, et al. (1997) Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinemia in neural-tube defects and vascular disease. Q J Med 90:511-517
28. Van Der Put NMJ, Garbreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051
29. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase(MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172
30. Wilcken DEL, Wang XL, Sim AS, McCredie RM (1996) Distribution in healthy and coronary population of the methylenetetrahydrofolate reductase(MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 16:878-882
31. Williams RR, Malinow MR, Hunt SC, Upson B, Wu LL, Hopkins PN, Stults BN, Kuida H (1990) Hyperhomocyst(e)inemia in Utah siblings with early coronary disease. Cor Art Dis 1:681-685